Managing Oral Anticoagulation Requires Expert Experience and Clinical Evidence
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-006-5583-8.pdf
Reference20 articles.
1. Guyatt G, Schunemann HJ, Cook D, Jaeschke R, Pauker S. Applying grades of recommendation for antithrombotic and thrombolytic therapy: The Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:179S–187S.
2. Spyropoulos AC, Hayth KA, Jenkins P. Anticoagulation with anisindione in a patient with a warfarin-induced skin reaction. Pharmacotherapy 2003;23(4):533–536.
3. Sallah S, Thomas DP, Roberts HR. Warfarin and heparin-induced skin necrosis and the purple-toe syndrome: infrequent complications of anticoagulant therapy. Thromb Haemost 1997;78:785–790.
4. Owens JP, Mirtallo JM, Murphy CC. Oral anticoagulation in patients with short-bowel syndrome DICP 1990;24(6):585–589.
5. Harrington DJ, Underwood S, Morse C, Shearer MJ, Tuddenham EG, Mumford AD. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in Vitamin K epoxide reductase complex subunit 1. Thromb Haemost 2005;93(1):23–26.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Venous Thromboembolism: Classification, Risk Factors, Diagnosis, and Management;ISRN Hematology;2011-10-17
2. Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban – an oral, direct factor Xa inhibitor – in elderly Chinese subjects;Thrombosis and Haemostasis;2010
3. Novel Anticoagulant Therapy: Principle and Practice;Anticoagulants, Antiplatelets, and Thrombolytics;2010
4. Terapia transfusional en cirugía vascular;Tratado de Medicina Transfusional Perioperatoria;2010
5. Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects;British Journal of Clinical Pharmacology;2009-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3